Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
China · Delayed Price · Currency is CNY 25.90
+0.16 (0.62%)
May 21, 2026, 3:04 PM CST
SHE:301111 Revenue
In the year 2025, Guangdong Lifestrong Pharmacy had annual revenue of 314.64M CNY with 12.92% growth. Guangdong Lifestrong Pharmacy had revenue of 66.18M in the quarter ending March 31, 2026, a decrease of -6.54%.
Revenue
314.64M
Revenue Growth
+12.92%
P/S Ratio
13.09
Revenue / Employee
471.72K
Employees
667
Market Cap
4.12B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 314.64M | 36.00M | 12.92% |
| Dec 31, 2024 | 278.64M | -13.76M | -4.71% |
| Dec 31, 2023 | 292.40M | 9.06M | 3.20% |
| Jan 1, 2023 | 283.34M | -66.45M | -19.00% |
| Jan 1, 2022 | 349.79M | 8.83M | 2.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jinling Pharmaceutical Company | 3.16B |
| Jinhe Biotechnology CO., LTD. | 2.99B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 1.78B |
| Zhuhai Rundu Pharmaceutical | 1.19B |
| Tibet Weixinkang Medicine | 1.16B |
| LanZhou Foci Pharmaceutical | 910.98M |
| Shandong Wohua Pharmaceutical | 818.16M |
| Newland Pharmaceutical | 659.54M |